[Therapeutic use of interferon: current trends and prospects]

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

Journal of viral hepatitis·2003

Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection.

Ultrasound in medicine & biology·2001

Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.

Hepato-gastroenterology·1998

Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.

Hepato-gastroenterology·1997

Radiological changes and circulating immune complexes in patients with urinary schistosomiasis.

British journal of urology·1989

Immunological alterations associated with recurrent herpes simplex genitalis.

Clinical immunology and immunopathology·1989

[The human genome project: reflections of an expert].

Medicina (Florence, Italy)·1990

[Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].

Medicina (Florence, Italy)·1990

[Clinical usefulness of a new echocardiographic window: the transesophageal approach].

Medicina (Florence, Italy)·1990

[Skin disease in Basedow's disease].

Medicina (Florence, Italy)·1990

[Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].

Medicina (Florence, Italy)·1990

[Clinical manifestations correlated with anticardiolipin antibodies in systemic lupus erythematosus: preliminary results of a prospective study].

Medicina (Florence, Italy)·1990

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Related Experiment Videos

[Therapeutic use of interferon: current trends and prospects]

Related Concept Videos

Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

Doppler sonography measurement of portal blood flow velocity after glucagon injection in patients with chronic HCV infection.

Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.

Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.

Radiological changes and circulating immune complexes in patients with urinary schistosomiasis.

Immunological alterations associated with recurrent herpes simplex genitalis.

[The human genome project: reflections of an expert].

[Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].

[Clinical usefulness of a new echocardiographic window: the transesophageal approach].

[Skin disease in Basedow's disease].

[Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].

[Clinical manifestations correlated with anticardiolipin antibodies in systemic lupus erythematosus: preliminary results of a prospective study].

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Related Experiment Videos

[Therapeutic use of interferon: current trends and prospects]

Related Concept Videos

Related Articles